Blockage of the HERG human cardiac K+ channel by the gastrointestinal prokinetic agent cisapride

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 42, Issue 5, 1997, Pages

  Mohammad, Saeed ^a   Zhou, Zhengfeng ^a   Gong, Qiuming ^a   January, Craig T ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 4244207380     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Ahmed, S. R and S. M. Wolfe. Cisapride and torsades de pointes. Lancet 345:508,1995.
2. Bran, S W. A. Murray, I. B. Hirsh, and J. P. Palmer. Long QT syndrome during high-dose cisapride. Arch. Intern. Med. 155: 765-768,1995.
3. Briejer, M. R L. M. A. Akkermans, and J. A. J. Schuurkes. Gastrointestinal prokinetic benzamides: the pharmacology underlying stimulation of motility. Pharmacol. Rev. 47:631-651,1995.
4. Craig, D. A and D. E. Clark. Pharmacological characterization of a neuronal receptor for 5-hydroxytryptamine in guinea pig ileum with properties similar to 5-hydroxytryptamine 4 receptor. J. Pharmacol. Exp. Ther. 252:1378-1386,1990.
5. Curran, M. E I. Splawski, K. W. Timothy, G. M. Vincent, E. D. Green, and M. T. Keating. A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell 80: 795-803,1995.
6. Den Hertog, A and J. Van Den Akker. The effect of cisapride on smooth muscle cells of guinea pig taenia caeci. Eur. J. Pharmacol. 126:31-35,1986.
7. Hamill, O. P A. Marty, E. Neher, B. Sakmann, and F. J. Sigworth. Improved patch-clamp techniques for high resolution current recording from cells and cell-free membrane patches. Pflügers Arch. 391:85-100,1981.
8. Kaumann, A. J. 5-HT4-like receptors in mammalian atria. J. Neural Transm. 34:195-201,1991.
9. Kilbinger, H A. Gebauer, J. Haas, H. Ladinsky, and C. A. Rizzi. Benzimidazolones and renzapride facilitates acetylcholine release from guinea-pig myenteric plexus via 5-HTi receptors. Naunyn Schmiedebergs Arch. Pharmacol. 351:229-236, 1995.
10. McCallum, R. W C. Prakash, D. Camboli-Richards, and K. L. Goa. Cisapride: a preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use as a prokinetic agent in gastrointestinal motility disorders. Drugs 36: 652-681,1988.
11. Ohno, N M. Itoh, Y.Yokohama, T. Takenichi, and H. Suzuki. Effects of cisapride on electrical and mechanical smooth muscles of the guinea-pig (Abstract). Gastroenterology 104: A560,1993.
12. Olsson, S and I. R. Edwards. Tachycardia during cisapride treatment. BMJ 305:748-749,1992.
13. Puisieux, F. L M. M. Adamantidis, B. M. Dumotier, and B. A. Dupuis. Cisapride-induced prolongation of cardiac action potential and early afterdepolarization in rabbit purkinje fibres. Er. J. Pharmacol. 117:1377-1379,1996.
14. Roy, M R. Dumaine, and A. Brown. HERG, a primary human ventricular target of the nonsedating antihistamine terfenadine. Circulation 94:817-823,1996.
15. Sanguinetti, M. C C. Jiang, M. E. Curran, and M. T. Heating. A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the /KT potassium channel. Cell 81: 299-307,1995.
16. Shuurkes, J. A. J A. L. Meulemans, H. Obertop, and L. M. A. Akkermans. 5-HT4 receptors on the human stomach. J. Gastrointest. Motil. 3:199,1991.
17. Snyders, D. J and A, Chaudhary. High affinity open channel block by dofetilide of HERG expressed in a human cell line. Mol. Pharmacol. 49:949-955,1996.
18. Suessbrich, H S. Waldegger, F. Lang, and A. E. Busch. Blockade of HERG channels expressed in Xenopus oocytes by the histamine receptor antagonists terfenadine and astemizole. FEES Lett. 385: 77-80,1996.
19. Tarn, F. S. F K. Hillier, K. T. Bunce, and C. D. Grossman. Differences in response to 5-HT4 agonists and antagonists of the 5-HT4-like receptor in human colon circular smooth muscle. Br. J. Pharmacol. 115:172-176,1995.
20. Taniyama, K S. Nakayama, K. Takeda, S. Matsuyama, J. Shirakawa, I. Sano, and C. Tanaka. Cisapride stimulates motility of the intestine via the 5-hydroxytryptamine receptors. J. Pharmacol. Exp. Ther. 258:1098-1104,1991.
21. Trudeau, M. C J. W. Warmke, B. Ganetzky, and G. A. Robertson. HERG, a human inward rectifier in the voltagegated potassium channel family. Science 269:92-95,1995.
22. Trudeau, M. C J. W. Warmke, B. Ganetzky, and G. A. Robertson. HERG sequence correction. Science 272:1087,1996.
23. Vorperian, V. R Z. Zhou, S. Mohammad, T. J. Hoon, C. Studenik, and C. T. January. Torsades de pointes with an antihistamine metabolite: potassium channel block with desmethylastemizole.J. Am. Coll. Cardiol. 28:1556-1561,1996.
24. Warmke, J. W and B. Ganetzky. A family of potassium channel genes related to eag in Drosophilia and mammals. Proc. Natl. Acad. Sci. USA 91:3438-3442,1994.
25. 25a. Wiseman, L. R and D. Faulds. Cisapride. An updated review of its pharmacology and therapeutic efficacy as a prokinetic agent in gastrointestinal motility disorders. Drugs 47:116-152,1994.
26. Wymore, R. S G. A. Gintant, R. T. Wymore, J. E. Dixon, D. McKlnnon, and I. S. Cohen. Tissue and species distribution of mRNAfor the /Kr-like K channel, erg. Circ. Res. 80:261-268, 1997.
27. Wysowski, D. K and J. Bacsanyi. Cisapride and fatal arrhythmia. N. Engl. J. Med. 335:290-291,1996.
28. Zhou, Z Q. Gong, B. Ye, F. Fan, J. C. Makielski, G. A. Robertson, and C. T. January. Electrophysiological and pharmacological properties of HERG channels in a stably transfected human cell line (Abstract). Biophys. J. 72: A225,1997.